Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-UMIN000024452
JPRN-UMIN000024452CompletedPhase 1

Sentinel lymph node biopsy for non-melanoma skin cancers - SLNB for NMSC

Kumamoto university0 sites100 target enrollmentStarted: October 18, 2016Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
100
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •The patients who have definite lymph node metastasis or distant metastasis

Investigators

Similar Trials

Completed
Phase 2
Feasibility of sentinel lymph node biopsy for acquired clinical node-negative breast cancer after neoadjuvant therapy in node-positive breast cancer, multi-centric, single arm, phase II, confirmatory studyBreast cancer
JPRN-UMIN000030510Osaka City General Hospital19
Completed
Phase 2
Sentinel lymph node biopsy feasibility study in patients with primary cutaneous melanomaMelanomaCancer
ISRCTN80602070Sponsor not defined - Record supplied by Institute of Cancer Research120
Not yet recruiting
Unknown
Mapping lymphatic drainage patterns in recurrent oral cavity squamous cell carcinoma using sentinel lymph node biopsy.
CTRI/2024/05/067253I
Recruiting
Not Applicable
Avoid axillary Sentinel Lymph node biopsy After Neoadjuvant chemotherapy Trial
KCT0006371Samsung Medical Center178
Active, not recruiting
Not Applicable
Feasibility of lymph node removal after chemotherapy in breast cancer patientsCancerBreast cancer
ISRCTN31364289The First Hospital of China Medical University500